Trends in Immunology

Contents page + Editorial Board
pp. i-i(1)

VIP: a very important peptide in T helper differentiation
pp. 221-224(4)
Author: Delgado M.

Bioinformatics for characterisation of allergens, allergenicity and allergic crossreactivity
pp. 225-228(4)
Authors: Brusic V.; Petrovsky N.

2-microglobulin as a potential initiator of inflammatory responses
pp. 228-229(2)
Authors: Xie J.; Yi Q.

Response to Xie and Yi: Ankylosing spondylitis: a ₂m-deposition disease?
pp. 229-230(2)
Authors: Uchanska-Ziegler B.; Ziegler A.

How to 'spot' a real killer
pp. 231-231(1)
Authors: Snyder J.E.; Mosmann T.R.

Response to Snyder and Mosmann: Killing HIV-1 versus killing cells
pp. 231-232(2)
Author: Yang O.O.

Melanoma immunotherapy: a battle against radicals?
pp. 232-233(2)
Author: Hellstrand K.

Response to Hellstrand: The jury on radicals is still out
pp. 234-234(1)
Authors: Mantovani A.; Sica A.

Linear '2-0-1' lymphocyte development: hypotheses on cellular bases for immunity
pp. 235-241(7)
Authors: Perussia B.; Loza M.J.

Tolerance, DCs and tryptophan: much ado about IDO
pp. 242-248(7)
Authors: Grohmann U.; Fallarino F.; Puccetti P.

Altering T-cell activation by targeting the multidomain tyrosine kinase Itk
pp. 249-253(5)
Authors: Kanner S.B.; Perez-Villar J.J.

Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?
pp. 254-258(5)
Authors: Netea M.G.; van der Meer J.W.M.; van Deuren M.; Jan Kullberg B.

Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE
pp. 259-263(5)
Authors: Tsokos G.C.; Nambiar M.P.; Tenbrock K.; Juang Y.-T.

Invariant chain, a chain of command
pp. 264-268(5)
Authors: Matza D.; Kerem A.; Shachar I.

The immune response to parasitic helminths: insights from murine models
pp. 269-277(9)
Authors: Gause W.C.; Urban J.F.; Stadecker M.J.

Viral inhibition of MHC class II antigen presentation
pp. 278-285(8)
Authors: Hegde N.R.; Chevalier M.S.; Johnson D.C.